Member Info for goupplease

If it opens up it was a buy

I am behind the new way of life at nfx.
As I have said finance to finance ,
Scientists to scientists,
Let's have some new deals and news

I decided to invest in nfx ,
I want to leave the deals to a competent financial side,
Till we get an rns we don't even know 002 exists

Yes soup I firmly believe we have no deals on going ,
We have the science to sell ,
We now have to sell it .

The only way is up .
We can only flourish on positive news.
You might be sick of my whinging but I am sick of podcasts with absolutely no foundation
You can give it large when you have achieved not on the promised land .
Not one thing has been achieved even 001 is in tatters

The most important part is to win back respect from the market,
It's at zero.
No matter what this board reckons we need a correction in pr.

Things have been said about the past ,
Let's face it the indicators from the podcasts never materialised
Dress it up how you like but it's nearly the end June.
The bod have restructured and we will go foward from here .
Forget about the past.

The phrase I would use here is "horses for courses"
Financial is a different ball game to science .

Well done soup , you have done some research.
I would like to think those with contacts are working hard to rescue what Disney would call a mickey mouse affair .
To lose china and then have Japan stalled, to put it kindly we need to recreate some sort of relationship with the market ,
Anybody can see what's happened here , covid has been a blessing for them , giving an excuse , it's just a case of waiting for news and hope it's positive.

working as a consultant to nfx and specifically the provision of investor relations advisory and services..

Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs. Nuformix risk-mitigated development strategy has resulted in a pipeline of discoveries through which it has developed and patented novel forms of approved small molecules.

Nuformix is targeting high-value unmet needs via drug repurposing with a lead programme in fibrosis (NXP002).

Last week was a great opportunity to sell and buy back .
OK missed,
I think the report that retail gone so well , we can jet back , with ocado coming target 1.80p .

I think we have started deal making from scratch ,
Patience will have to be shown ,
A new dawn

Will regret not holding

The loose ones are being taken , let's get to next leg soon

Has gone quite !

A merger , cerp will die without funding , covid and oil prices done cerp ,
You still got a better chance

4.16 about are buys

Well and truly under radar , expect a decent move here

Won't be too much longer , hopefully this month .
It's when not if ,
We shouldn't have to wait much longer then this will really move.
The H&W side is a nice bonus